Vidofludimus is an orally active inhibitor for dihydroorotate dehydrogenase (DHODH) and also is a novel modulator for farnesoid X receptor (FXR). Vidofludimus, as an immunomodulatory agent, can be used for the research of autoimmune disorders such as inf
Molekulargewicht:
355.36
Reinheit:
99.11
CAS Nummer:
[717824-30-1]
Formel:
C20H18FNO4
Target-Kategorie:
Dihydroorotate Dehydrogenase,FXR,Interleukin Related
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten